MedPath

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

Not Applicable
Active, not recruiting
Conditions
Uterine Cervical Neoplasms
Interventions
Behavioral: Community-Based Education
Behavioral: Navigation to Screening
Behavioral: HPV Self-Sampling
Registration Number
NCT04557423
Lead Sponsor
Fox Chase Cancer Center
Brief Summary

This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Asian American (Korean, Vietnamese, and Chinese) women. All women will receive an educational program and navigation assistance. Women in the intervention condition will also receive a self-sampling kit for self-collection of a cervical sample for HPV testing. The investigators will evaluate whether the inclusion of a self-sampling kit increases the proportion of Asian American women who participate in cervical cancer screening.

Detailed Description

Aim 1: Compare rates of providing a self-collected sample vs. obtaining clinic-based screening among 1100 Asian American women. It is hypothesized that the proportion of women in the HPV self-sampling program who provide a self-collected sample will be higher than the proportion of women in the clinic-based program who obtain clinic-based screening.

Aim 2: Examine mediators of participation. The investigators will examine both individual- and social/environmental-level factors associated with participation across both programs. It is hypothesized that higher levels of perceived self-efficacy, lower levels of embarrassment, and fewer barriers will be associated with higher rates of participation in both conditions. Further, it is hypothesized that women in the HPV self-sampling program will report greater self-efficacy, less embarrassment, and fewer barriers compared to women in the clinic-based program.

Aim 3: Assess the relative cost-effectiveness of HPV self-sampling vs. clinic-based screening. The investigators will conduct an incremental cost-effectiveness analysis from a societal perspective incorporating trial-based direct medical and participant-borne costs associated with HPV self-sampling vs. clinic-based screening. It is hypothesized that the self-sampling program will be less costly to implement and achieve a higher participation rate.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
797
Inclusion Criteria
  • Women who are of Asian race and self-identify as Korean, Vietnamese, or Chinese
  • are 30-65 years of age
  • are overdue for cervical cancer screening (e.g., no cytology-based screening within the past 3 years; no hrHPV testing either alone or in combination with cytology in the past 5 years)
Exclusion Criteria
  • have a prior diagnosis of cervical cancer or cervical abnormality (e.g., dysplasia)
  • had a hysterectomy with removal of the cervix
  • have a compromised immune system (e.g., known HIV)
  • unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HPV Self-SamplingCommunity-Based EducationPreviously tested evidence-based intervention (i.e. culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided). Participants will also receive a self-sampling kit.
HPV Self-SamplingHPV Self-SamplingPreviously tested evidence-based intervention (i.e. culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided). Participants will also receive a self-sampling kit.
Evidence-Based InterventionCommunity-Based EducationCulturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided.
Evidence-Based InterventionNavigation to ScreeningCulturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided.
HPV Self-SamplingNavigation to ScreeningPreviously tested evidence-based intervention (i.e. culturally appropriate educational intervention focused on cervical cancer screening, with navigation assistance provided). Participants will also receive a self-sampling kit.
Primary Outcome Measures
NameTimeMethod
Participation in screening6 months

The number of women who obtain clinic-based screening or return a self-collected sample

Secondary Outcome Measures
NameTimeMethod
Program delivery cost6 months

The costs associated with delivering each program. This will include: (1) Participant costs (time spent participating in educational sessions and time required to complete screening; transportation costs, if incurred); (2) Screening costs (cost of clinic-based screening, or cost of the HPV self-sampling kit); (3) Program delivery costs (community health educator time for conducting the educational programs, time will be valued at wage rates including benefits; costs of educational materials \[flyers, booklets\] and reminder letters); (4) Navigation costs (time and labor involved in navigating women to the clinic for screening will be documented using a log of CHE time and expenses incurred).

Trial Locations

Locations (1)

Temple University Lewis Katz School of Medicine

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath